COc1ccc2[nH]c3c(c2c1)CCN1C(=O)C(CC(=O)NCc2cccc(C(F)(F)F)c2)C[C@H](C(=O)N(C(C)C)C(C)C)[C@@]31C
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?